Healthcare

Imugene (ASX:IMU) is a clinical-stage immuno-oncology company developing therapies designed to use the immune system to fight cancer. Its lead program, azer-cel, is focused on allogeneic or “off-the-shelf” CAR-T cell therapy, an approach aimed at addressing some of the limitations associated with patient-specific cell …

SomnoMed (ASX:SOM) develops custom oral appliances for obstructive sleep apnoea, providing dental-style devices designed to help keep airways open during sleep. The company operates within the global sleep-disorder market, offering an alternative treatment option for patients who may not prefer traditional therapies.

Beamtree (ASX:BMT) is a healthcare technology company providing software solutions that help hospitals and health systems improve clinical coding, data quality and decision-making. Its products include coding audit solutions, knowledge networks and the RippleDown clinical decision-support platform.

Sigma Healthcare (ASX:SIG) has strengthened its position as a major healthcare and pharmacy retailBusinessfollowing its merger with Chemist Warehouse. The FY2026 result highlighted the impact of the expanded business model, with significant growth in revenue, earnings and profitability. The company’s transformation from a traditional …

CSL Limited (ASX:CSL) delivered a challenging but strategically important FY2026 result, with a statutory loss driven by significant impairment and restructuring charges, while investor focus shifted towards future growth prospects. The blood-products and vaccines company described the period as a reset year, highlighting operational …

Ramsay Health Care CARES (ASX:RHCPA) are approaching their next interim distribution, keeping the listed preference security in focus for investors assessing income-generating opportunities. RHCPA is a Convertible Adjustable RateEquitySecurity issued by Ramsay Health Care. It is not an ordinary share and is not a …

Few newly listed companies attract as much curiosity as a clinical-stage medical technology play, and Ceretas (ASX:CTS) has emerged as a closely watched small-cap company since joining the Australian market. The University of Queensland spin-out is developing a therapeutic ultrasound platform aimed at Alzheimer’s …